1985
Ellex Medical Lasers Limited founded in Adelaide, Australia
1992
Ellex Medical Lasers Limited commences contract manufacturing for a number of leading ophthalmic companies, including Alcon.
2006
Ellex Medical Lasers Limited launches direct market presence and relinquishes contract manufacturing arrangements.
2007
Ellex Medical Lasers Limited acquires Eye Cubed™ ultrasound business from US-based Innovative Imaging, Inc.
2014
Ellex Medical Lasers Limited acquires iTrack™ canaloplasty portfolio from US-based iScience Interventional, Inc.
2020
Ellex Medical Lasers Limited divests Ellex Laser & Ultrasound business and changes name to Nova Eye Medical Limited (ASX:EYE).
2020
Nova Eye Medical Limited acquires the Molteno3® Glaucoma Drainage Device business from Molteno Ophthalmic Limited.
With its sales headquarters based in Fremont, California, Nova Eye Medical is supported by a global network of more than 50 distribution partners. Manufacturing facilities are located in Fremont, California and Dunedin, New Zealand.
USA
Nova Eye, Inc
Nova Eye, Inc
- Headquarters USA
- iTrack™ Manufacturing
- iTrack™ R&D
- iTrack™ Quality & Regulatory
At the heart of Nova Eye Medical is our iTrack™ canaloplasty device. An implant-free, tissue-sparing procedure, canaloplasty is helping to redefine the treatment of glaucoma in its early stages.
Acquired from world-leader Molteno Ophthalmic Ltd, the Molteno3® Glaucoma Drainage Device is a highly effective option for cases of severe and complex glaucoma and provides the added benefit of a simplified and faster surgical procedure.
Ellex is a registered trademark of Quantel Medical
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More
The cookies do not store any personalised information. Learn More